Artículos por temáticas

Trials of pharmacological interventions for Tourette syndrome: a systematic review.

Waldon K, Hill J, Termine C, Balottin U, Cavanna AE.

Behav Neurol. 2013;26(4):265-73. doi: 10.3233/BEN-2012-120269. Review.

Thalamic deep brain stimulation for Tourette syndrome.

Ackermans L, Neuner I, Temel Y, Duits A, Kuhn J, Visser-Vandewalle V.

Behav Neurol. 2013;27(1):133-8. doi: 10.3233/BEN-120301. Review. No abstract available.

Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.

Rizzo R, Gulisano M, Calì PV, Curatolo P.

Eur J Paediatr Neurol. 2013 Sep;17(5):421-8. doi: 10.1016/j.ejpn.2013.01.005. Review.

Current controversies on the role of behavior therapy in Tourette syndrome.

Scahill L, Woods DW, Himle MB, Peterson AL, Wilhelm S, Piacentini JC, McNaught K, Walkup JT, Mink JW.

Mov Disord. 2013 Aug;28(9):1179-83. doi: 10.1002/mds.25488. Review.

Brain mechanisms for prepulse inhibition in adults with Tourette syndrome: initial findings.

Zebardast N, Crowley MJ, Bloch MH, Mayes LC, Wyk BV, Leckman JF, Pelphrey KA, Swain JE.

Psychiatry Res. 2013 Oct 30;214(1):33-41. doi: 10.1016/j.pscychresns.2013.05.009.

Motor control, habits, complex motor stereotypies, and Tourette syndrome.

Singer HS.

Ann N Y Acad Sci. 2013 Nov;1304:22-31. doi: 10.1111/nyas.12281.

Clinical pharmacology of nondopaminergic drugs in Tourette syndrome.

Hartmann A.

Int Rev Neurobiol. 2013;112:351-72. doi: 10.1016/B978-0-12-411546-0.00011-1. Review.

Motor excitability is reduced prior to voluntary movements in children and adolescents with Tourette syndrome.

Jackson SR, Parkinson A, Manfredi V, Millon G, Hollis C, Jackson GM.

J Neuropsychol. 2013 Mar;7(1):29-44. doi: 10.1111/j.1748-6653.2012.02033.x.

Environmental factors in Tourette syndrome.

Hoekstra PJ, Dietrich A, Edwards MJ, Elamin I, Martino D.

Neurosci Biobehav Rev. 2013 Jul;37(6):1040-9. doi: 10.1016/j.neubiorev.2012.10.010. Review.

Co-morbid disorders in Tourette syndrome.

Mol Debes NM.

Behav Neurol. 2013;27(1):7-14. doi: 10.3233/BEN-120275. Review.

Immune-mediated animal models of Tourette syndrome.

Hornig M, Lipkin WI.

Neurosci Biobehav Rev. 2013 Jul;37(6):1120-38. doi: 10.1016/j.neubiorev.2013.01.007. Review.

Sequence analysis of SLITRK1 for var321 in Danish patients with Tourette syndrome and review of the literature.

Yasmeen S, Melchior L, Bertelsen B, Skov L, Mol Debes N, Tümer Z.

Psychiatr Genet. 2013 Jun;23(3):130-3. doi: 10.1097/YPG.0b013e328360c880. Review.

The effectiveness of habit reversal therapy in the treatment of Tourette syndrome and other chronic tic disorders: a systematic review.

Dutta N, Cavanna AE.

Funct Neurol. 2013 Jan-Mar;28(1):7-12. Review.

Detecting a clinically meaningful change in tic severity in Tourette syndrome: a comparison of three methods.

Jeon S, Walkup JT, Woods DW, Peterson A, Piacentini J, Wilhelm S, Katsovich L, McGuire JF, Dziura J, Scahill L.

Contemp Clin Trials. 2013 Nov;36(2):414-20. doi: 10.1016/j.cct.2013.08.012.

Cognitive aspects of hyperactivity and overactivity in preadolescents with tourette syndrome.

Laverdure A, O'Connor K, Lavoie ME.

Psychiatry J. 2013;2013:198746. doi: 10.1155/2013/198746.